Universal Technical Institute, Inc. (UTI) Stock Price & Analysis
Universal Technical Institute, Inc. (UTI) closed at USD 21.66 on Thursday, October 22, 2026, up 4.13% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 20.8; the Oct 22, 2026 session ranged USD 20.14–21.69 on volume of 1,502,205 shares. Market capitalization is $1.19B, with a 52-week range of USD 18.02–51.34 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/UTI.md
Key facts (UTI)
- Last four reported quarters (through Jun 30, 2026): revenue $884M, net income $34.3M (3.9% margin), free cash flow -$22.9M (SEC filings).
- Valuation: P/E 34.8x (avg 23.9x at the last 3 fiscal year-ends), EV/EBITDA 14.6x, net cash $10.1M.
- 1 of 80 tracked superinvestors hold UTI (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 38.83 (range 30–48).
- Total return with dividends: 1Y -36.2% vs S&P 500 +14.9%; 5Y +222.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-18, EPS estimate USD 0.33, revenue estimate $235M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (UTI)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $335M | $419M | $607M | $733M | $836M | $884M |
| Operating income | $14.9M | $22.4M | $21.4M | $58.9M | $83.5M | $44.3M |
| Net income | $14.6M | $25.8M | $12.3M | $42.0M | $63.0M | $34.3M |
| EPS (diluted) | $0.17 | $0.38 | $0.13 | $0.75 | $1.13 | — |
| Free cash flow | -$6.1M | -$33.4M | -$7.5M | $61.6M | $55.4M | -$22.9M |
| Operating margin | 4.5% | 5.3% | 3.5% | 8.0% | 10.0% | 5.0% |
| Net margin | 4.4% | 6.2% | 2.0% | 5.7% | 7.5% | 3.9% |
| Revenue growth | +11.4% | +25.0% | +45.0% | +20.6% | +14.0% | — |
| Cash + short-term investments | $134M | $66.5M | $152M | $162M | $169M | — |
| Total debt | $30.7M | $67.5M | $162M | $126M | $87.1M | — |
Fiscal years end Sep. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (UTI)
P/E 34.8x · P/S 1.4x · EV/EBITDA 14.6x · EV/Sales 1.3x · P/B 3.5x · FCF yield -1.92% · Earnings yield 2.87% · Net cash $10.1M · EV $1.18B
P/E at fiscal year-ends: Sep 2025 28.7x, Sep 2024 19.7x, Sep 2023 23.4x.
Superinvestors (SEC 13F-HR, Q2 2026) (UTI)
1 of 80 tracked investors hold UTI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.04% | $24.4M | Added +20.8% |
Analysts (UTI)
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 38.83 (low 30, high 48).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-06 | Truist Securities | Target lowered | Buy | $47 → $38 |
| 2026-08-06 | B. Riley Securities | Target lowered | Buy | $49 → $48 |
| 2026-08-06 | Rosenblatt | Maintained | Buy | $45 |
| 2026-06-29 | Truist Securities | Target raised | Buy | $40 → $47 |
Total return (dividends reinvested) (UTI)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -36.2% | +222.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -36.3% | +26.3% |
| Volatility (annualized) | 72.5% | 50.6% |
| Max drawdown | -63.9% (Jul 2026→Sep 2026) | -60.0% (Jul 2026→Sep 2026) |
UTI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.33 | $0.52 | -37.3% | $235.0M | 6 |
| Next quarter (ends Dec 2026) | $0.16 | $0.18 | -11.2% | $234.9M | 5 |
| Current fiscal year (ends Sep 2026) | $0.60 | $0.78 | -22.3% | $896.2M | 6 |
| Next fiscal year (ends Sep 2027) | $0.73 | $0.85 | -13.7% | $971.9M | 6 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 21.66 |
|---|---|
| Change | ▲ 4.13% (up) |
| Previous Close | USD 20.8 |
| Open | USD 20.8 |
| Day Range | USD 20.14 – 21.69 |
| 52-Week Range | USD 18.02 – 51.34 |
| Volume | 1,502,205 shares |
| Market Cap | $1.19B |
| Exchange | NYQ |
Technical Analysis (UTI)
Nexqual's technical model rates UTI "NEUTRAL" based on 3 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 60.02 (neutral) |
| vs SMA50 | Above (USD 21.18) |
| MACD | -0.22 (negative) |
Analyst Ratings (UTI)
Wall Street analysts rate UTI "Buy" based on 6 analysts, with a mean price target of USD 38.83 (range USD 30–48), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 38.83 |
| High Target | USD 48 |
| Low Target | USD 30 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (UTI)
| Next Earnings Date | 2026-11-18 |
|---|---|
| Revenue Estimate | $235.03M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.04 vs est 0.02 ▲ beat |
| 2026-03-31 | USD 0.01 vs est 0 ▲ beat |
| 2025-12-31 | USD 0.23 vs est 0.14 ▲ beat |
| 2025-09-30 | USD 0.34 vs est 0.26 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (UTI)
| Total Revenue | $883.60M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.20% |
| Gross Margin | +55.05% |
| Operating Margin | +1.98% |
| Profit Margin | +3.88% |
| ROE | +10.53% |
| Debt / Equity | 1.04 |
| Current Ratio | 1.3 |
| Total Cash | $170.61M |
| Total Debt | $359.47M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$22.87M (-2.6% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (UTI)
Nexqual rates Universal Technical Institute, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Solid — Revenue +14% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 55%, operating 2% (last 12 months) |
| Balance Sheet | Mixed — $170M cash and investments vs $160M debt (Jun 2026, SEC), net cash |
| Cash Flow | Weak — FCF negative: -$23M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — ROE 11%, ROA 3.5% |
Ownership (UTI)
| Insider Ownership | +2.50% |
|---|---|
| Institutional Ownership | +114.61% |
| Shares Outstanding | 55.10M |
| Float | 53.80M |
| Short % of Float | +13.94% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (UTI)
Universal Technical Institute, Inc. is led by Jerome A. Grant, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| CEO & Director | Jerome A. Grant |
|---|---|
| Executive VP & CFO | Bruce Schuman |
| Senior VP & Chief Operating Officer | Kevin Prehn |
| Vice President of Corporate Finance | Matthew Kempton |
Major Backers & Investors (UTI)
Notable institutional backers of Universal Technical Institute, Inc. include Price (T.Rowe) Associates Inc, Driehaus Capital Management, LLC, Thrivent Financial For Lutherans, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 4.69% |
| Driehaus Capital Management, LLC | 4.54% |
| Thrivent Financial For Lutherans | 3% |
| Hood River Capital Management LLC | 2.83% |
| Praetorian PR LLC | 2.45% |
| American Century Companies Inc | 2.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 13.72% |
| Vanguard Group | 4.02% |
| State Street | 3.43% |
| Dimensional Fund Advisors | 2.34% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFYA | Afya Limited | USD 14.91 | ▲ 0.07% |
| COUR | Coursera, Inc. | USD 5.07 | ▲ 2.01% |
| APEI | American Public Education, Inc. | USD 48.86 | ▲ 2.26% |
| PXED | Phoenix Education Partners, Inc | USD 24.57 | ▲ 3.85% |
| STRA | Strategic Education, Inc. | USD 81.59 | ▲ 2.56% |
| LINC | Lincoln Educational Services Co | USD 21.96 | ▲ 3.34% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt